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Background
Despite extensive pre-procedure evaluation, greater than
mild paravalvular leak (PVL) occurs in over 10% of
patients undergoing transcatheter aortic valve replacement
(TAVR) and is associated with worse outcomes. Echocar-
diography, the standard method of imaging PVL, often has
limited utility due to frequently multiple eccentric regurgi-
tant jets. Acoustic shadowing from the valve stent and
native aortic valve calcification may lead to further under-
estimation of PVL. Cardiovascular magnetic resonance
(CMR) is considered the gold standard for quantification
of valvular regurgitation. We evaluated the utility of CMR
to grade PVL severity and predict outcomes in patients
with suboptimal echocardiography.
Methods
Seventeen non-operative post-TAVR patients (NYHA
class III-IV; age 84 ± 5 yrs) underwent CMR due to PVL
and symptoms out of proportion to echocardiographic
findings or suboptimal echocardiographic study. CMR
was performed on a Siemens Avanto 1.5 T with velocity
phase imaging in the ascending aorta for flow quantifica-
tion. CMR PVL severity was graded by regurgitant frac-
tion (RF; mild≤20%, moderate 21-39%, severe ≥40%).
Short- and intermediate-term follow-up was conducted
after CMR. Patients were followed-up for symptoms and
a composite outcome of repeat invasive therapy, heart
failure hospitalization, or death.
Results
CMR was performed as early as 2 days and as late as
35 months post-TAVR in both the inpatient (n = 9) and
outpatient (n = 8) settings. PVL grading was mild in 11,
moderate in 3, and severe in 3 patients. Compared to
echocardiography, PVL severity was reclassified in 47%
(5 upgraded to moderate or severe; 3 downgraded to
mild). CMR findings guided further management in 71%
(medical therapy including diuresis in 8 with mild or
moderate PVL; invasive therapy including vascular plug
closure or valve in valve deployment in 4 with moderate
or severe PVL). At short-term follow-up (mean 1.7 ± 1.4
months), 76% had NYHA class improvement. At inter-
mediate-term follow-up (mean 11.6 ± 1.0 months), 65%
had persistent improvement in NYHA class (Table 1).
At one year, 47% (n = 8) met the composite outcome.
Outcome free survival was significantly better with
≤mild PVL compared to > mild PVL (73% vs 17%; p <
0.05). The mean RF was larger in those reaching the
composite outcome compared to those not (24 ± 19% vs
11 ± 8%), with a trend towards significance (p = 0.08;
Table 2). Patients undergoing repeat CMR after invasive
PVL therapy (n = 3) demonstrated a reduction in mean
RF from 43% to 12%.
Conclusions
CMR stratifies PVL severity in symptomatic patients with
suboptimal echocardiography or discrepant results. CMR is
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Table 1 CMR clinical utility and follow-up symptoms.
Category Result
CMR clinical utility PVL grading reclassification 47% (18/17)
Guided further management 71% (12/17)
Follow-up symptoms Short-term (≤3 months)







CMR = cardiovascular magnetic resonance; PVL = paravalvular leak; NYHA =
New York Heart Association.
Hartlage et al. Journal of Cardiovascular Magnetic
Resonance 2014, 16(Suppl 1):O102
http://www.jcmr-online.com/content/16/S1/O102
© 2014 Hartlage et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
useful in guidance of specific post procedure therapy and
has prognostic importance, with greater than mild PVL
(RF > 20%) associated significantly with worse outcomes.
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Table 2 CMR PVL grading and prognosis.
Category Result Significance
Prognosis ≤Mild PVL 73% outcome* free
survival
p < 0.05




Mean RF 11 ± 8% p = 0.08
+ Composite
outcome*
Mean RF 24 ± 19%
PVL = paravalvular leak; RF = regurgitant fraction; *Composite outcome = repeat
invasive therapy, heart failure hospitalization, or death within a year of CMR.
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